Longevity Health Holdings, Inc.
XAGE· OTC
XAGELongevity Health Holdings, Inc.
Filed Aug 14, 2023 · 10-Q · 45 days after period end · 0001193125-23-212538
| Metric | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|
| Revenue | $0.00 | — | — |
| Net Income | $317.51K | -$346.99K | -$6.37K |
| EPS Diluted | -$5.00 | — | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
ended Jun 30, 2023 · filed Aug 14, 2023 · 45 d after period end
